LHC Group, Inc. (NASDAQ:LHCG)

hoping for MACD crossover, divergence of STO and 50day support

IBD

Health care niche business. Significant cost advantage. Proven mgt team in an industry with good growth prospects fueled by aging of US population. Historically strong profit performance. The impact of medicare and health reform will remain a critical factor to their business.

On earnings, lokking for some gian here.

it is undervalued and the management is really business oriented, They look ast it as if it's their own family business.

that's make this stock wonderfull, besides, they are providing healthcare facilities for old people which is a great achievement for itself

Rapidly growing need for in-home health care services provided by companies like LHCG. To date most services have been provided by regional, privately owned firms. LHCG is consolidating the industry in the Southeastern states. Economies of scale arise from consolidated management, marketing, billing and insurance coverage. Expect LHCG to continue to grow in the next 5 years as it expands through acquisition.

awesome value...

Target $30

great "value" numbers. i see this stock hitting 40 in 3 years or less.

peg = .65

Forward P/E (fye 31-Dec-08) = 12.62

Total Debt/Equity = 0.027

and it's been hurting since april. you can't ask for much more.

Properties are in underserved area but where employees tend to be available. Have cash to keep acquiring which means a more efficient back office.

home heath care will increase in the coming years.

good cash flow, revenue for a new company

Solid growth, aging population, increasing interest in less-expensive home care. Company has great fundamentals. Stock has recently been way oversold.

Incredibly low float. 49% insider holding.

Serving baby boomers, lhcg smokes market averages in coming years. Add in some more expansion in home care and this is my best and safest pick.

I just added this stock to my real portfolio. LHC Group. provides provide post-acute healthcare services primarily to Medicare beneficiaries in rural markets in the southern United States. It offers various home-based services, as well.
A few things I like about this company. One is that demograhics are turning in their favor. As our population lives longer more and more care for the elderly will be necessary. The second part I like about this company is that it's growth strategy is based on buying smaller companies at a discount. It's debt to equity ratio is a low .041.

IBD Stats:

Overall rating: 84 / A

EPS Rating: 98

SMR Rating: A

The high ratings in EPS and Sales Profit Margins and ROE (SMR Rating) show how well this company is run.

This is my cursory analysis.. Let me know what you think.

My blog today:

LHC Group provides post-acute healthcare services primarily to Medicare beneficiaries in rural markets in the southern United States. I recorded my CAPS Outperform on Jan 17 (contributes 4.02 to my score), and bought it for my portfolio a few days later on Jan 25 (up 11%, yes that's 11% in one month). It's one of my "demographic" picks, looking forward to the needs of aging boomers (of which I will eventually be one).

Their returns are excellent, with good growth in both sales and EPS, almost no debt, and margins significantly higher than most of their competition. Cash flow has risen from $0.57/share in '03 to 1.16 in '04, 1.12 in '05, and 1.38 TTM ('06 earnings will be announced March 1). Free cash flow has grown from -0.12/share in '03 to 0.16 in '04, 0.25 in '05, and 1.29 TTM. It's almost "under the radar", with only 10 Jaywalk analysts following the stock (up one from the last few months), at a Jaywalk consensus of 2.6. Reuters has it as an Outperform. Insiders own/control about 33% of the stock, and institutions own 65% (increased by over 13% in the past 3 months).

They've got a good reputation, have been growing rapidly by buying other successful and good-reputation companies. I wouldn't want to try to guess whether it'll keep climbing anywhere near this rate, but as long as their March 1 earnings announcement doesn't disappoint, I would expect the stock to continue growing at least a little bit better than the S&P.

little competition in rural home healthcare market. appetite for acquisition. currently operate in approximately 100 markets, management has identified about 500 they could be successful in. strong financials. purchase private companies at discount (last major purchase for .75 x rev) and then LHCG sells approx 2.5 x rev.

baby boomers?